Streetbeat News

Products Services

INBX

SNY

Sanofi SA's Q4 earnings were impacted by generic competition for Aubagio, but gains from Dupixent and the launch of Altuviiio and Beyfortus helped offset losses. Operating income fell 5.2% to €2.6 billion, with revenues up 1.8% to €10.92 billion, missing consensus estimates. The company aims to become a pure-play biopharma entity by 2030, with significant sales from new Pharma launches. Sanofi also acquired assets related to Inhibrx Inc's INBRX-101. The company expects a low single-digit percentage decrease in 2024 adjusted EPS due to higher taxes but anticipates a strong rebound next year.

Portfolio Pulse from Vandana Singh

February 01, 2024 | 2:24 pm

CRDO

Credo Technology Group announced the expansion of its SerDes technology to TSMC N3 and N7/N6 processes, enhancing its programmable power versus channel reach performance. This development marks a significant step in Credo's offerings, potentially impacting its market position and partnerships.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 2:20 pm

CRBP

Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) announced a public offering of 4.325 million shares at $19.00 each to raise approximately $82.2 million. The funds are intended for clinical development and general corporate purposes. This follows recent positive clinical study results of CRB-701, which led to a significant stock price increase. However, CRBP shares are currently down 1.02% at $26.22 in premarket trading.

Portfolio Pulse from Vandana Singh

February 01, 2024 | 2:18 pm

TWOU

2U, Inc. has announced a new partnership with the University of Surrey to offer more than 15 online professional certificate programs in various fields including technology, business management, healthcare, and sustainability. This collaboration aims to expand educational opportunities and cater to the growing demand for online learning solutions.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 2:15 pm

MULN

Mullen Automotive has invoiced a total of $17,318,000.00 to date for its commercial vehicles, indicating a significant revenue stream from this segment of its business.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 2:14 pm

IMCR

DELFI has announced a collaboration with Immunocore Holdings to explore the use of the DELFI-TF cancer monitoring assay. This partnership aims to enhance cancer treatment monitoring by leveraging DELFI's technology.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 2:11 pm

PTON

During a conference call, a Peloton executive stated that the relaunch of the Tread+ treadmill is expected to help increase the company's revenue in the fourth quarter on a year-over-year basis.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 2:09 pm

LUCY

Innovative Eyewear has commenced the shipping of its Nautica Smart Eyewear Collection, marking a significant step in the company's product distribution.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 2:06 pm

PTON

During a conference call, a Peloton executive stated that the company expects to grow its subscriber base in Q3, including both connected fitness and app subscribers.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 2:00 pm

NIO

NIO Inc. (NYSE:NIO) shares are up in premarket trading after reporting an 18.2% year-over-year increase in vehicle deliveries for January 2024, totaling 10,055 vehicles. Cumulative deliveries reached 459,649. The company also announced strategic partnerships with JAC Group and Chery Automobile for battery swapping, adding to previous collaborations with Changan Automobile and Geely Group. Furthermore, NIO co-established Zhongan Energy to build 1,000 battery swap stations in China, aiming to expand the power network and promote battery swapping.

Portfolio Pulse from Nabaparna Bhattacharya

February 01, 2024 | 1:59 pm